Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2016 | Lymphoma highlights from EHA 2016

Raúl Córdoba • 9 Jun 2016
EHA 2016
Diffuse Large B-Cell Lymphoma Follicular Lymphoma Hodgkin Lymphoma Mantle Cell Lymphoma Non-Hodgkin Lymphoma

Raúl Córdoba, MD, PhD of University Hospital Infanta Sofía, Madrid, Spain discusses his highlights from sessions on lymphoma at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark. First, he talks about the chemo-free strategies to treat patients without chemotherapies with targeted therapies and monoclonal antibodies. The second topic Dr Córdoba highlights is the issues that arise with the aging European population; such as treating elderly lymphoma patients and how to identify frail patients and patients with co-morbidities.

More from Raúl Córdoba

2:03
Comprehensive geriatric assessments can aid in selecting treatment for elderly patients with CLL
Raúl Córdoba • 7 Oct 2023
2:08
The differences in outcomes and treatment in CLL patients with mutated and unmutated IGHV
Raúl Córdoba • 7 Oct 2023
2:12
Real-world safety and efficacy of first- and second-generation BTK inhibitors in CLL
Raúl Córdoba • 7 Oct 2023
2:20
Clinical relevance of geriatric assessment
Raúl Córdoba • 22 Jun 2020

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals